| Company | Designation | Period |
|---|---|---|
| Cipla | Management Staff | Sep 2004 – Oct 2007 |
| Torrent Pharmaceuticals Ltd | Research Associate | Oct 2007 – Apr 2010 |
| Zydus Group | General Manager | Jun 2016 – Mar 2018 |
| Cadila Pharmaceuticals | Technical Supervisor | Jun 2000 – Jun 2001 |
| CADILA HEALTHCARE LTD | Chemist | Jun 1999 – Jun 2000 |
| DIA | Chair - DIA Young Professional Chapter | Jan 2010 – Jan 2011 |
| Astron Reserach Pvt Limited | Research Associate | Feb 2003 – Sep 2004 |
| Zydus Group | Senior General Manager | Apr 2018 – Jun 2022 |
| Torrent Pharmaceuticals Ltd | Scientist I | Apr 2010 – Jun 2016 |
| ISAZI GROUP OF COMPANIES | Co-Founder | Jul 2022 – Present |
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Official Email: Via Isazi corporate communication desk.
Personal Contact: Not publicly disclosed.
What is Nirav Chokshi's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Isazi's official communication channels.
Is this an official profile?
No — independently created using public data.
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)